Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A subtype of Machado-Joseph disease characterized by Parkinsonian symptoms that respond particularly well to levodopa treatment.
Biomarker and diagnostic research for Machado-Joseph disease type 4 has been reported in the published literature.
No clinical trials have been registered for Machado-Joseph disease type 4.
35 publications have been identified in PubMed for Machado-Joseph disease type 4. Research spans Epidemiology / Natural History (31%), Basic Science / Preclinical (23%), and Diagnostic / Biomarker (17%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 11 | 31% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 2:53 PM UTC
Common questions about Machado-Joseph disease type 4
Laboratory research
8 |
23% |
Testing and diagnosis research | 6 | 17% |
Clinical study results | 4 | 11% |
Research summaries | 3 | 9% |
Other research | 1 | 3% |
Patient case studies | 1 | 3% |
New treatment approaches | 1 | 3% |
Podlasiak M (2026). [PMID: 41609435](https://pubmed.ncbi.nlm.nih.gov/41609435/). *FEBS J*. [Diagnostic / Biomarker]
Leeuwenberg KE (2026). [PMID: 41501569](https://pubmed.ncbi.nlm.nih.gov/41501569/). *J Neurol*. [Epidemiology / Natural History]
Petit E (2026). [PMID: 41150672](https://pubmed.ncbi.nlm.nih.gov/41150672/). *Brain*. [Diagnostic / Biomarker]
Chiu C (2026). [PMID: 41756352](https://pubmed.ncbi.nlm.nih.gov/41756352/). *Exp Ther Med*. [Diagnostic / Biomarker]
Ye M (2026). [PMID: 41983302](https://pubmed.ncbi.nlm.nih.gov/41983302/). *Mol Genet Genomic Med*. [Epidemiology / Natural History]
Roney M (2026). [PMID: 41644963](https://pubmed.ncbi.nlm.nih.gov/41644963/). *Sci Rep*. [Diagnostic / Biomarker]
Chen LW (2026). [PMID: 42183960](https://pubmed.ncbi.nlm.nih.gov/42183960/). *Cerebellum*. [Basic Science / Preclinical]
Damásio J (2025). [PMID: 39936868](https://pubmed.ncbi.nlm.nih.gov/39936868/). *Mov Disord Clin Pract*. [Review / Meta-Analysis]
Sommaruga N (2025). [PMID: 40289053](https://pubmed.ncbi.nlm.nih.gov/40289053/). *Cerebellum*. [Basic Science / Preclinical]
Qiu H (2025). [PMID: 40207891](https://pubmed.ncbi.nlm.nih.gov/40207891/). *Eur J Neurol*. [Basic Science / Preclinical]